PEAK6 Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.2M Buy
17,200
+2,700
+19% +$603K 0.01% 1039
2024
Q2
$2.78M Sell
14,500
-11,300
-44% -$2.29M 0.01% 1167
2024
Q1
$5.11M Buy
25,800
+15,600
+153% +$2.86M 0.01% 825
2023
Q4
$1.75M Sell
10,200
-32,400
-76% -$4.98M 0.01% 1629
2023
Q3
$6.3M Buy
+42,600
New +$7.7M 0.03% 598
2023
Q1
Sell
-900
Closed -$187K 4858
2022
Q4
$187K Sell
900
-3,500
-80% -$769K ﹤0.01% 3329
2022
Q3
$961K Buy
4,400
+4,300
+4,300% +$979K ﹤0.01% 2247
2022
Q2
$21K Sell
100
-14,100
-99% -$3M ﹤0.01% 5729
2022
Q1
$3.44M Buy
14,200
+8,000
+129% +$1.94M 0.01% 1377
2021
Q4
$1.61M Buy
6,200
+2,500
+68% +$649K ﹤0.01% 2103
2021
Q3
$975K Sell
3,700
-73,300
-95% -$20M ﹤0.01% 2628
2021
Q2
$19M Buy
+77,000
New +$16.2M 0.05% 385
2021
Q1
Sell
-48,200
Closed -$10.2M 5441
2020
Q4
$10.2M Buy
48,200
+10,600
+28% +$2.11M 0.02% 664
2020
Q3
$6.45M Sell
37,600
-58,000
-61% -$10.7M 0.02% 814
2020
Q2
$18.4M Buy
95,600
+59,300
+163% +$9.7M 0.06% 280
2020
Q1
$5.35M Buy
+36,300
New +$5.78M 0.03% 515
2019
Q2
Sell
-7,000
Closed -$728K 4200
2019
Q1
$728K Sell
7,000
-35,000
-83% -$3.61M ﹤0.01% 2098
2018
Q4
$4.78M Buy
42,000
+33,700
+406% +$3.61M 0.03% 667
2018
Q3
$957K Buy
+8,300
New +$909K ﹤0.01% 2025

Other funds holding RMD

PEAK6 Investments's RMD Position: Q3 2024 in Review

PEAK6 Investments increased its ResMed (RMD) stake by 680% in Q3 2024, buying an estimated $3.5M and bringing the position to 17,958 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #1010.

PEAK6 Investments first reported a position in RMD in Q1 2019 and has held it in 13 quarters since. The position peaked at $9.53M in Q1 2024. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • PEAK6 Investments held 17,958 shares of ResMed worth $4.38M as of Q3 2024.
  • PEAK6 Investments bought 15,657 ResMed shares in Q3 2024, an estimated $3.5M.
  • ResMed made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1010 holding.
  • PEAK6 Investments first reported a position in ResMed in Q1 2019 and has held it in 13 quarters since.
  • PEAK6 Investments's ResMed position peaked at $9.53M in Q1 2024.
  • 802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.